Septicemia in the United States dialysis population, 1991 to 1999

被引:131
作者
Foley, RN
Guo, HF
Snyder, JJ
Gilbertson, DT
Collins, AJ
机构
[1] US Renal Data Syst, Coordinating Ctr, Minneapolis, MN 55404 USA
[2] Univ Minnesota, Minneapolis, MN 55455 USA
来源
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2004年 / 15卷 / 04期
关键词
D O I
10.1097/01.ASN.0000119144.95922.C4
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The clinical epidemiology of septicemia in dialysis populations remains poorly defined. In this historical cohort study of 393,451 U.S. dialysis patients, International Classification of Disease, Ninth Revision, Clinical Modification discharge diagnosis codes were used to compare first-year septicemia admission rates in annual incident cohorts from 1991 to 1999 and to calculate subsequent cardiovascular event and mortality rates. Hemodialysis (compared with peritoneal dialysis) as initial therapy and starting dialysis in more recent years were the principal antecedents of septicemia. In hemodialysis patients, adjusted first admission rates (expressed throughout as first episodes per 100 patient-years) rose by 51%, from 11.6 in 1991 to 17.5 in 1999. In peritoneal dialysis patients, rates rose from 5.7 in 1991, peaked at 9.2 in 1997, and declined to 8.0 in 1999. Mortality rates after septicemia were similar to mortality rates after major cardiovascular events. Septicemia was associated with developing myocardial infarction, congestive heart failure, stroke, and peripheral vascular disease with adjusted risk ratios of 4.1, 5.5, 4. 1, and 3.8 in the initial 6 mo after admission for septicemia and 1.7, 2.0, 2.0, and 1.6 after 5 yr, respectively. Septicemia, which is associated with increased cardiovascular and death risk, has become more common in dialysis patients in the United States.
引用
收藏
页码:1038 / 1045
页数:8
相关论文
共 22 条
  • [1] Abbott KC, 2001, CLIN NEPHROL, V56, P124
  • [2] Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care
    Angus, DC
    Linde-Zwirble, WT
    Lidicker, J
    Clermont, G
    Carcillo, J
    Pinsky, MR
    [J]. CRITICAL CARE MEDICINE, 2001, 29 (07) : 1303 - 1310
  • [3] Outpatient vancomycin use and vancomycin-resistant enterococcal colonization in maintenance dialysis patients
    Atta, MG
    Eustace, JA
    Song, XY
    Perl, TM
    Scheel, PJ
    [J]. KIDNEY INTERNATIONAL, 2001, 59 (02) : 718 - 724
  • [4] CANADIAN HEMODIALYSIS MORBIDITY STUDY
    CHURCHILL, DN
    TAYLOR, DW
    COOK, RJ
    LAPLANTE, P
    BARRE, P
    CARTIER, P
    FAY, WP
    GOLDSTEIN, MB
    JINDAL, K
    MANDIN, H
    MCKENZIE, JK
    MUIRHEAD, N
    PARFREY, PS
    POSEN, GA
    SLAUGHTER, D
    ULAN, RA
    WERB, R
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1992, 19 (03) : 214 - 234
  • [5] Cohen G, 1997, KIDNEY INT, V52, pS79
  • [6] Type of vascular access and mortality in US hemodialysis patients
    Dhingra, RK
    Young, EW
    Hulbert-Shearon, TE
    Leavey, SF
    Port, FK
    [J]. KIDNEY INTERNATIONAL, 2001, 60 (04) : 1443 - 1451
  • [7] K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification - Foreword
    Eknoyan, G
    Levin, NW
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (02) : S14 - S266
  • [8] Hoen B, 1998, J AM SOC NEPHROL, V9, P869
  • [9] Medical progress: The pathophysiology and treatment of sepsis.
    Hotchkiss, RS
    Karl, IE
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (02) : 138 - 150
  • [10] A randomized controlled trial of topical exit site mupirocin application in patients with tunnelled, cuffed haemodialysis catheters
    Johnson, DW
    MacGinley, R
    Kay, TD
    Hawley, CM
    Campbell, SB
    Isbel, NM
    Hollett, O
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2002, 17 (10) : 1802 - 1807